Tower Research Capital LLC (TRC) - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 273 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.6%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q2 2024$62,668
-65.1%
3,222
-32.7%
0.00%
-75.0%
Q1 2024$179,619
+1.9%
4,786
+51.9%
0.00%
+100.0%
Q4 2023$176,274
+58.0%
3,150
+16.5%
0.00%
-33.3%
Q3 2023$111,540
-70.5%
2,704
-60.0%
0.00%
-76.9%
Q2 2023$377,590
+100056.5%
6,762
+0.1%
0.01%
+8.3%
Q1 2023$377
+255.7%
6,758
+132.9%
0.01%
+200.0%
Q4 2022$106
-100.0%
2,902
-85.0%
0.00%
-55.6%
Q3 2022$551,000
-30.1%
19,347
+11.2%
0.01%
-50.0%
Q2 2022$788,000
+35.2%
17,398
+127.2%
0.02%
+200.0%
Q1 2022$583,000
-3.2%
7,657
+89.7%
0.01%
-40.0%
Q4 2021$602,000
+58.4%
4,037
+54.4%
0.01%0.0%
Q3 2021$380,000
-86.4%
2,615
-81.7%
0.01%
-86.3%
Q2 2021$2,795,000
-1.8%
14,273
-9.2%
0.07%
+52.1%
Q1 2021$2,846,000
+466.9%
15,725
+343.5%
0.05%
+220.0%
Q4 2020$502,000
+1631.0%
3,546
+1408.9%
0.02%
Q3 2020$29,000
-63.3%
235
-73.4%
0.00%
-100.0%
Q2 2020$79,000
-80.3%
883
-83.2%
0.00%
-90.9%
Q4 2019$401,000
+60.4%
5,263
+6.3%
0.03%
+94.1%
Q3 2019$250,0004,9520.02%
Other shareholders
10X GENOMICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Venrock Management VI, LLC 2,106,757$117,894,122100.00%
Blue Water Life Science Advisors, LP 194,500$10,884,2209.53%
Sands Capital Ventures, LLC 481,770$26,959,8497.50%
Meritech Capital Associates V L.L.C. 494,236$27,657,4476.73%
Decheng Capital LLC 359,554$20,120,6425.62%
Iron Triangle Partners LP 479,374$26,825,7693.47%
Brown Capital Management 3,527,297$197,387,5402.96%
Freshford Capital Management, LLC 305,798$17,112,4562.78%
SVB WEALTH LLC 1,446,552$80,949,0661.97%
Capital Impact Advisors, LLC 23,594$1,320,3201.74%
View complete list of 10X GENOMICS INC shareholders